I agree it is a good time to top up. Sorry for my out burst. Its just one of my shares is weighting on my portfolio. Open Orphan and another company are the only ones in the blue.
Open Orphan in less than 12 months since its IPO is now a full-service niche pharmaceutical services CRO focusing predominantly upon running clinical trials for orphan drug companies and also helping vaccine manufacturers develop their new vaccines. Coronavirus is unfortunately travelling around the world, but as such, companies are now having to spend serious money developing vaccines and we are there to help out with the process. https://www.valuethemarkets.com/2020/02/27/open-orphan-primed-to-support-coronavirus-vaccine-work-after-bringing-in-world-leading-experts-orph/